Justices Pass On 2nd Circ. Fosamax Jaw-Injury Ruling

Law360, New York (June 3, 2013, 3:03 PM EDT) -- The U.S. Supreme Court declined Monday to review the Second Circuit's ruling that a physician's contradictory testimony doomed a onetime Fosamax user's suit in multidistrict litigation over jaw injuries allegedly caused by the bone drug.

The high court denied a petition for certiorari filed by Linda Secrest, the plaintiff in one of seven bellwethers in the litigation over jaw-related claims. Secrest claimed her use of Fosamax between 1998 and 2005 caused her to develop osteonecrosis of the jaw and other injuries in her jaw and oral...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.